SBRT With Immunotherapy in Early Stage Non-small Cell Lung Cancer: Tolerability and Lung Effects

NCT03383302 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Non-small Cell Lung Cancer Stage II
Non-small Cell Lung Cancer Stage I

Interventions

RADIATION: Stereotactic body radiotherapy
DRUG: Nivolumab

Sponsor

Royal Marsden NHS Foundation Trust

Collaborators

[object Object]